Cargando…
Effects of glycoprotein IIb/IIIa receptor blocker (tirofiban) in acute coronary syndromes angiographic, scintigraphic and molecular biology studies
Autores principales: | Rizk, A, El-Fattah, AA, Tayeh, O, El-Naggar, A, El-Aziz, AA, Ashraf, M, El-Ghawaby, H, Sayed, M, Mokhtar, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333349/ http://dx.doi.org/10.1186/cc1229 |
Ejemplares similares
-
Platelet dysfunction in acute coronary syndromes: diagnostic aspects and relation to angiographic patency
por: Nagi, HK, et al.
Publicado: (2002) -
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023) -
Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016) -
Stent-Assisted Coil Embolization Using Only a Glycoprotein IIb/IIIa Inhibitor (Tirofiban) for Ruptured Wide-Necked Aneurysm Repair
por: Lee, Sang Hyub, et al.
Publicado: (2018) -
Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
por: Lambrechts, Kate, et al.
Publicado: (2018)